Skip to main content
Premium Trial:

Request an Annual Quote

Bake Cookies? Check. Knit Sweater? Check. Prevent Cancer? Check.


In a commentary published recently in the Proceedings of the Royal Society, the University of Adelaide's Jack da Silva says grandmothers may have helped to lower the risk of cancer, reports New Scientist's Michael Slezak. A study from the US last year found that women with either of the BRCA genes — which are linked to breast cancer — tend to have more children than women without the genes. In fact, da Silva says, the increase in fertility is so high that after four generations, the BRCA mutations should be ubiquitous. And yet, they're not. Why? Well, says Slezak, da Silva thinks "it all comes down to grandma."

Most people who develop breast cancer and die because of BRCA mutations do so after menopause, after they've had children, Slezak says. It doesn't limit the number of children they have, but it may limit the number of grandchildren they have, since they can no longer help their daughters care for offspring. Under da Silva's theory, "when humans were mostly hunter-gatherers, grandmother care was so important for the survival of youngsters that it may have cancelled out the fertility advantage of those with BRCA1 or BRCA2," Slezak adds. Though the majority of humans haven't lived in a hunter-gatherer society for many generations, da Silva says that the effect may have been strong enough in our ancestors to carry through to today.

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.